Pfizer Inc's forecast says that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.
Could Nifty Soar To 29,000 In 2026? Osho Krishan Weighs In
Gold & Silver For The Long Term: SIP, Physical Or ETFs - What’s The Right Strategy?
From Volatility To Opportunity: What 2026 Holds For Indian Markets
“Knowledge Is India’s Capital”: Gadkari Says Converting Innovation Into Wealth Will Shape Nation’s
“True Nationalism Is Self-Reliance”: Gadkari Pushes Innovation, Defence, Clean Energy
